KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Q: What does CUSIP 483497103 represent in this 13F holders report?

CUSIP 483497103 is the security identifier for KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in Q4 2018?

56 institutional investors reported KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share for Q4 2018. Use the holders table for investor-level position and value details.

CUSIP: 483497103

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 51,679,622
Total 13F shares: 12,995,790
Share change: +463,253
Total reported value: $256,399,000
Price per share: $19.75
Number of holders: 56
Value change: +$7,695,219
Number of buys: 31
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 483497103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
SV Health Investors, LLC	13F	Company	5%	2,579,490	$57,033,000	—	30 Sep 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.8%	1,441,070	$31,862,000	—	30 Sep 2018	13F
Vivo Capital, LLC	13F	Company	2.6%	1,359,149	$30,051,000	—	30 Sep 2018	13F
VHCP Management III, LLC	13F	Company	2.5%	1,284,931	$28,410,000	—	30 Sep 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.7%	900,000	$19,899,000	—	30 Sep 2018	13F
VHCP Management II, LLC	13F	Company	1.5%	759,181	$16,785,000	—	30 Sep 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.3%	650,000	$14,372,000	—	30 Sep 2018	13F
BVF INC/IL	13F	Company	1.2%	609,014	$13,465,000	—	30 Sep 2018	13F
INTERWEST VENTURE MANAGEMENT CO	13F	Company	0.75%	388,766	$8,596,000	—	30 Sep 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.59%	305,187	$6,748,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	0.57%	296,581	$6,558,000	—	30 Sep 2018	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.62%	322,436	$5,467,000	—	30 Sep 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.44%	225,000	$4,975,000	—	30 Sep 2018	13F
Boxer Capital, LLC	13F	Company	0.39%	200,000	$4,422,000	—	30 Sep 2018	13F
FARALLON CAPITAL MANAGEMENT LLC	13F	Company	0.39%	200,000	$4,422,000	—	30 Sep 2018	13F
Broadfin Capital, LLC	13F	Company	0.29%	150,000	$3,317,000	—	30 Sep 2018	13F
Stonepine Capital Management, LLC	13F	Company	0.27%	138,100	$3,053,000	—	30 Sep 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.25%	128,844	$2,849,000	—	30 Sep 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.23%	117,349	$2,595,000	—	30 Sep 2018	13F
WEDGE CAPITAL MANAGEMENT L L P/NC	13F	Company	0.13%	67,460	$1,492,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	64,245	$1,419,000	—	30 Sep 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	52,041	$1,151,000	—	30 Sep 2018	13F
Informed Momentum Co LLC	13F	Company	0.08%	41,896	$926,000	—	30 Sep 2018	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.08%	41,000	$907,000	—	30 Sep 2018	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.08%	40,000	$884,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.06%	30,694	$678,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.05%	27,068	$598,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	0.04%	19,309	$427,000	—	30 Sep 2018	13F
DAFNA Capital Management LLC	13F	Company	0.03%	17,725	$392,000	—	30 Sep 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.03%	17,551	$388,000	—	30 Sep 2018	13F
Telemetry Investments, L.L.C.	13F	Company	0.03%	16,000	$354,000	—	30 Sep 2018	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	12,740	$282,000	—	30 Sep 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	12,383	$274,000	—	30 Sep 2018	13F
Spark Investment Management LLC	13F	Company	0.02%	12,328	$272,000	—	30 Sep 2018	13F
Virtu Financial LLC	13F	Company	0.02%	9,755	$216,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	8,091	$179,000	—	30 Sep 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	5,612	$124,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.01%	4,202	$93,000	—	30 Sep 2018	13F
FIRST QUADRANT LLC/CA	13F	Company	0.01%	3,054	$68,000	—	30 Sep 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,742	$39,000	—	30 Sep 2018	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	656	$15,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0%	660	$14,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	245	$5,000	—	30 Sep 2018	13F
FEDERATED HERMES, INC.	13F	Company	0%	148	$3,000	—	30 Sep 2018	13F
Valeo Financial Advisors, LLC	13F	Company	0%	142	$3,000	—	30 Sep 2018	13F
BARCLAYS PLC	13F	Company	0%	71	$2,000	—	30 Sep 2018	13F
Advisor Group, Inc.	13F	Company	0%	50	$1,000	—	30 Sep 2018	13F

Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2018

As of 31 Dec 2018, KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,995,790 shares. The largest 10 holders included SV Health Investors, LLC, RA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, VHCP Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, VHCP Management II, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ADAGE CAPITAL PARTNERS GP, L.L.C., Ghost Tree Capital, LLC, and INTERWEST VENTURE MANAGEMENT CO. This page lists 56 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.